CVS Health’s Aetna pushes to cut prior-authorization delays by accelerating approvals and bundling decisions

CVS Health’s Aetna is leaning into a common health-care bottleneck: prior authorization, the administrative step insurers require before certain services are approved. In a recent discussion published by Yahoo Finance, Aetna highlighted operational changes designed to shrink paperwork and shorten wait times for clinicians and patients who need care decisions.

According to the report, Aetna has worked to streamline its prior-authorization workflow so that it can approve more than 95% of eligible requests within 24 hours. Prior authorization is often criticized for causing delays in treatment, adding administrative workload for provider offices, and increasing uncertainty for patients. Aetna’s focus, as described in the article, is to make those decisions faster when a request meets eligibility criteria.

The company also pointed to an expansion of what it calls “bundled approvals.” While the post does not provide granular definitions, the concept is that instead of approving each component of a care pathway in isolation, insurers can group approvals to reduce repeated back-and-forth. The stated goal is to speed access to care by minimizing the administrative steps needed to move from authorization to treatment.

Aetna’s effort fits into a broader industry push to reduce administrative burden in U.S. health care. Insurers and large health systems have increasingly targeted prior authorization reforms, faster utilization management workflows, and automation to reduce manual review time. These moves are especially relevant as provider groups continue to report high staff time spent on authorization paperwork.

For CVS Health, the strategy has potential operational and customer implications. Faster administrative cycles can reduce avoidable denials or rework and can improve satisfaction among physicians and other ordering providers who must document medical necessity. At the same time, the administrative flow sits inside a larger reimbursement and care-management system, where insurers must balance speed with clinical review requirements.

The Yahoo Finance post provides several high-level performance claims, but it does not disclose additional metrics such as the proportion of all prior-authorization requests that fall within eligibility criteria, how “bundled approvals” are structured across service lines, or whether the 24-hour turnaround applies to specific categories of care.

It also does not describe the specific technologies, staffing changes, or policy adjustments underpinning the improvements, nor does it offer figures on patient outcomes tied to the faster approvals. For readers, that means the near-term takeaway is primarily about Aetna’s stated process targets rather than fully quantified clinical or economic results.

Looking ahead, the key question for the market is whether Aetna can sustain those approval-speed claims at scale and extend bundled approvals across more plans and care types. Provider groups and regulators are likely to keep scrutinizing not only timing but also transparency, appeal processes, and how eligibility is determined when insurers decide which requests qualify for faster handling.